| Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules A Hultberg, NJ Temperton, V Rosseels, M Koenders, M Gonzalez-Pajuelo, ... PloS one 6 (4), e17665, 2011 | 208 | 2011 |
| Nanobodies®: new ammunition to battle viruses P Vanlandschoot, C Stortelers, E Beirnaert, LI Ibañez, B Schepens, ... Antiviral research 92 (3), 389-407, 2011 | 170 | 2011 |
| Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection LI Ibanez, M De Filette, A Hultberg, T Verrips, N Temperton, RA Weiss, ... Journal of Infectious Diseases 203 (8), 1063-1072, 2011 | 122 | 2011 |
| Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells Scientific reports 10 (1), 21779, 2020 | 92 | 2020 |
| Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion B Schepens, LIÍ Ibanez, S De Baets, A Hultberg, P Bogaert, P De Bleser, ... Journal of Infectious Diseases 204 (11), 1692-1701, 2011 | 75 | 2011 |
| Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge FM Cardoso, LI Ibañez, S Van den Hoecke, S De Baets, A Smet, K Roose, ... Journal of virology 88 (15), 8278-8296, 2014 | 70 | 2014 |
| Natural and long-lasting cellular immune responses against influenza in the M2e-immune host M Schotsaert, T Ysenbaert, K Neyt, LI Ibañez, P Bogaert, B Schepens, ... Mucosal immunology 6 (2), 276-287, 2013 | 55 | 2013 |
| A20 deficiency in lung epithelial cells protects against influenza A virus infection J Maelfait, K Roose, L Vereecke, C Mc Guire, M Sze, MJ Schuijs, M Willart, ... PLoS pathogens 12 (1), e1005410, 2016 | 51 | 2016 |
| M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A LI Ibanez, K Roose, M De Filette, M Schotsaert, J De Sloovere, S Roels, ... PloS one 8 (3), e59081, 2013 | 47 | 2013 |
| Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages L Deng, LI Ibañez, V Van den Bossche, K Roose, SA Youssef, A De Bruin, ... PloS one 10 (5), e0126650, 2015 | 46 | 2015 |
| P/Q Ca2+ channels are functionally coupled to exocytosis of the immediately releasable pool in mouse chromaffin cells YD Álvarez, LI Ibañez, OD Uchitel, FD Marengo Cell calcium 43 (2), 155-164, 2008 | 39 | 2008 |
| Reverse engineering synthetic antiviral amyloids E Michiels, K Roose, R Gallardo, L Khodaparast, L Khodaparast, ... Nature communications 11 (1), 2832, 2020 | 34 | 2020 |
| Antibodies directed toward neuraminidase N1 control disease in a mouse model of influenza ER Job, M Schotsaert, LI Ibañez, A Smet, T Ysenbaert, K Roose, M Dai, ... Journal of Virology 92 (4), 10.1128/jvi. 01584-17, 2018 | 34 | 2018 |
| Influenza vaccines to control influenza-associated bacterial infection: where do we stand? I Christopoulou, K Roose, LI Ibañez, X Saelens Expert Review of Vaccines 14 (1), 55-67, 2015 | 25 | 2015 |
| Rapid recovery of releasable vesicles and formation of nonreleasable endosomes follow intense exocytosis in chromaffin cells AEP Bay, LI Ibañez, FD Marengo American Journal of Physiology-Cell Physiology 293 (5), C1509-C1522, 2007 | 25 | 2007 |
| Controlling influenza by cytotoxic T-cells: calling for help from destroyers M Schotsaert, LI Ibañez, W Fiers, X Saelens BioMed Research International 2010, 2010 | 24 | 2010 |
| The role of heterotypic DENV-specific CD8+ T lymphocytes in an immunocompetent mouse model of secondary dengue virus infection LB Talarico, JP Batalle, AB Byrne, JM Brahamian, A Ferretti, AG García, ... EBioMedicine 20, 202-216, 2017 | 19 | 2017 |
| Non-sterilizing, infection-permissive vaccination with inactivated influenza virus vaccine reshapes subsequent virus infection-induced protective heterosubtypic immunity from … A Choi, LI Ibañez, S Strohmeier, F Krammer, A García-Sastre, ... Frontiers in immunology 11, 537924, 2020 | 13 | 2020 |
| Covalent coupling of Spike’s receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2 Scientific reports 12 (1), 692, 2022 | 11 | 2022 |
| Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains LI Ibañez, CA Caldevilla, YP Rojas, N Mattion Vaccine 36 (12), 1592-1598, 2018 | 5 | 2018 |
